Novan, Inc. Purchase Agreements
10 Contracts & Agreements
- Amended and Restated Asset Purchase Agreement, dated September 1, 2023, by and among Novan, Inc., EPI Health, LLC and Ligand Pharmaceuticals, Incorporated (Filed With SEC on September 7, 2023)
- Asset Purchase Agreement, dated August 31, 2023, by and among Novan, Inc., EPI Health, LLC and Mayne Pharma LLC (Filed With SEC on September 7, 2023)
- Amendment No. 2 to Asset Purchase Agreement, dated August 21, 2023, by and among Novan, Inc., EPI Health, LLC and Ligand Pharmaceuticals, Incorporated (Filed With SEC on August 24, 2023)
- Asset Purchase Agreement, dated July 17, 2023, by and among Novan, Inc., EPI Health, LLC and Ligand Pharmaceuticals, Incorporated (Filed With SEC on July 17, 2023)
- Form of Securities Purchase Agreement, dated March 13, 2023, by and between the Company and the purchaser identified therein (Filed With SEC on March 16, 2023)
- Form of Securities Purchase Agreement, dated June 9, 2022, by and between the Company and the purchaser identified therein (Filed With SEC on June 10, 2022)
- Unit Purchase Agreement, dated as of (Filed With SEC on March 11, 2022)
- Royalty and Milestone Payments Purchase Agreement, dated April 29, 2019, by and between Novan, Inc. and Reedy Creek Investments LLC (Filed With SEC on February 18, 2022)
- Securities Purchase Agreement, dated March 24, 2020, by and between the Company and each Purchaser thereto (Filed With SEC on March 26, 2020)
- Royalty and Milestone Payments Purchase Agreement, dated April 29, 2019, by and between Novan, Inc. and Reedy Creek Investments LLC (Filed With SEC on August 13, 2019)
